We intensively studied 5 islet cell-antibody-positive (ICA+) first-degree relatives of type I (insulin-dependent) diabetic patients before overt diabetes. In total, 55 intravenous glucose tolerance tests (IVGTTs) and 83 fasting plasma glucose determinations were made over a maximum 4-yr period before diabetes. The 5 prediabetic relatives (not diabetic when initially studied but subsequently progressed to overt diabetes) as a group showed a progressive rise in fasting glucose (r = 0.58, P < 0.001, slope = 23.1 mg · dl1 yr1) and glucose at 60 min in IVGTT (r = 0.46, P = 0.01, slope = 47.5 mg · dl-1) beginning 1.5 yr before diabetes. During the 4.0- to 1.5-yr period before overt diabetes, no change was observed in fasting glucose or glucose at 60 min on IVGTT (fasting glucose: r = 0.21, P = 0.18, slope = 2.1 mg · dl-1 · yr-1; 60-min glucose: r = 0.08, P = 0.72, slope = 2.9 mg · dl-1 · yr-1). The positive predictive value for a fasting glucose >;108 mg/dl to be within 1.5 yr of diabetes was 100% (11 of 11 values). The negative predictive value of a stimulated insulin (1-min + 3-min insulin - 2 × basal insulin) level >24 μU/ml to be >1.5 yr from diabetes was 90% (9 of 10 values) and 100% (10 of 10 values) at >1 yr from overt diabetes. We tested these predictive values by applying fasting glucose >108 mg/dl and stimulated insulin >24 μU/ml to another prediabetic group (n = 14) not included in the original analysis because each individual had fewer measurements. Once again, the positive predictive value that diabetes would develop within 1.5 yr from the time of fasting glucose >108 mg/dl was 100% (5 of 5 values), and the negative predictive value of stimulated insulin >24 μU/ml was 63% (5 of 8 values) for 1.5 yr and 89% (6 of 7 values) for 1 yr. Finally, 16 ICA+ relatives who had not yet become diabetic lacked raised fasting glucose levels (14 of 16 patients) and had stimulated insulin levels >24 μU/ml.
Skip Nav Destination
Article navigation
Original Articles|
February 01 1990
Analysis of Metabolic Progression to Type I Diabetes in ICA+ Relatives of Patients With Type I Diabetes
David Bleich, MD;
David Bleich, MD
Joslin Diabetes Center, Brigham and Women's Hospital, New England Deaconess Hospital, and Harvard Medical School
Boston, Massachusetts
; and the University of California
Davis, Sacramento, California
Search for other works by this author on:
Richard A Jackson, MD;
Richard A Jackson, MD
Joslin Diabetes Center, Brigham and Women's Hospital, New England Deaconess Hospital, and Harvard Medical School
Boston, Massachusetts
; and the University of California
Davis, Sacramento, California
Search for other works by this author on:
J Stuart Soeldner, MD;
J Stuart Soeldner, MD
Joslin Diabetes Center, Brigham and Women's Hospital, New England Deaconess Hospital, and Harvard Medical School
Boston, Massachusetts
; and the University of California
Davis, Sacramento, California
Search for other works by this author on:
George S Eisenbarth, MD, PhD
George S Eisenbarth, MD, PhD
Joslin Diabetes Center, Brigham and Women's Hospital, New England Deaconess Hospital, and Harvard Medical School
Boston, Massachusetts
; and the University of California
Davis, Sacramento, California
Search for other works by this author on:
Address correspondence and reprint requests to George S. Eisenbarth, MD, PhD, loslin Diabetes Center, One Joslin Place, Boston, MA 02215.
Diabetes Care 1990;13(2):111–118
Article history
Received:
December 05 1988
Accepted:
April 06 1989
PubMed:
2190768
Citation
David Bleich, Richard A Jackson, J Stuart Soeldner, George S Eisenbarth; Analysis of Metabolic Progression to Type I Diabetes in ICA+ Relatives of Patients With Type I Diabetes. Diabetes Care 1 February 1990; 13 (2): 111–118. https://doi.org/10.2337/diacare.13.2.111
Download citation file: